Medical treatment of lung cancer

被引:3
作者
Kelly, K [1 ]
Mikhaeel-Kamel, N [1 ]
机构
[1] Univ Colorado, Ctr Canc, Lung Canc Program, Denver, CO 80262 USA
关键词
lung cancer; treatment; NSCLC; SCLC;
D O I
10.1097/00005382-199910000-00005
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Lung cancer is the leading cause of cancer deaths for both men and women in the United States. Most patients present with late stages of disease, rendering them incurable. Despite this dismal outcome, there is optimism; modern treatment for lung cancer has been shown to increase survival, improve quality of life, and be cost effective. This article reviews the current treatment strategies for non-small cell lung cancer and small cell lung cancer as well as discusses future treatments, including the exciting biologic agents that are in clinical trials.
引用
收藏
页码:257 / 265
页数:9
相关论文
共 68 条
[1]   Phase I trial of weekly paclitaxel in advanced lung cancer [J].
Akerley, W ;
Glantz, M ;
Choy, H ;
Rege, V ;
Sambandam, S ;
Joseph, P ;
Yee, L ;
Rodrigues, B ;
Wingate, P ;
Leone, L .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) :153-158
[2]  
ALBERTI W, 1995, BRIT MED J, V311, P899
[3]  
[Anonymous], P AM SOC CLIN ONCOL
[4]  
ARRIAGADA R, 1998, P AN M AM SOC CLIN, V17, pA457
[5]  
BARKLEY H, 1980, CANC B, V32, P113
[6]  
BELANGER JMR, 1997, TEC INSTR A, V18, P1
[7]  
Billingham LJ, 1997, LUNG CANCER S1, V18, P9
[8]  
Bonomi P, 1996, P AN M AM SOC CLIN, V15, P382
[9]  
Bunn PA, 1998, CLIN CANCER RES, V4, P1087
[10]  
BUNN PA, 1989, SEMIN ONCOL, V16, P27